Iris Breitkreutz und Patrick - Info zur Person

(1 - 9 von 13

)

History of Changes for Study: NCT ClinicalTrials.gov ·

clinicaltrials.gov

Contact:Principal Investigator: Mathias Witzens-Harig, Prof. Contact:Sub-Investigator: Patrick Wuchter, Dr. Contact:Sub-Investigator: Iris Breitkreutz, Dr. › ...

Dr. Thu T. Nguyen, MD | Temple, TX | US News Doctors

health.usnews.com

Marc-Steffen Raab, Iris Breitkreutz, Giovanni Tonon, Jing Zhang, Patrick Hayden, Thu T. Nguyen, Johannes Fruehauf, Boris Lin, Dharminder Chauhan, ... › doctors

The orally available multikinase inhibitor regorafenib (BAY )...

link.springer.com

Iris Breitkreutz; Klaus Podar; Vianihuini Figueroa-Vazquez; Scott Wilhelm; Patrick J. Hayden; Kenneth C. Anderson; Marc S. RaabEmail author. Iris Breitkreutz.

HEIDI: Breitkreutz, Iris: The orally available multikinase inhibitor ...

www.bing.com

NettetIris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, Scott Wilhelm, Patrick J. Hayden, Kenneth C. Anderson, Marc S. Raab: E-Jahr: 2018: Jahr: 23 January 2018: …

Dose-intensified bendamustine followed by autologous ...

pubmed.ncbi.nlm.nih.gov

von I Breitkreutz · · Zitiert von: 4 — Iris Breitkreutz , Natalia Becker , Axel Benner , Florentina Kosely , Christoph Heining , Jens Hillengass , Gerlinde Egerer , Anthony D Ho , Hartmut ... von I Breitkreutz · · Zitiert von: 8 — Iris Breitkreutz , Klaus Podar , Vianihuini Figueroa-Vazquez , Scott Wilhelm , Patrick J Hayden , Kenneth C Anderson , Marc S Raab ... › ...